Effect of a genomic classifier on adjuvant treatment decision-making among patients with high-risk pathology at radical prostatectomy: Results from the multicenter prospective PRO-IMPACT study.

Authors

null

John L. Gore

University of Washington, Seattle, WA

John L. Gore , Marguerite Du Plessis , Maria Santiago-Jimenez , Kasra Yousefi , Darby J. S. Thompson , David Y. T. Chen , William R. Clark , Michael E. Franks , Lawrence Ivan Karsh , Adam S. Kibel , Hyung Lae Kim , Brian R. Lane , Yair Lotan , William Thomas Lowrance , Paul Maroni , Scott David Perrapato , Edouard John Trabulsi , Robert J. Waterhouse Jr., Elai Davicioni , Daniel W. Lin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Epidemiology/Outcomes

Clinical Trial Registration Number

NCT02080689

Citation

J Clin Oncol 34, 2016 (suppl; abstr 5053)

DOI

10.1200/JCO.2016.34.15_suppl.5053

Abstract #

5053

Poster Bd #

310

Abstract Disclosures

Similar Posters

First Author: Todd Matthew Morgan

Poster

2018 Genitourinary Cancers Symposium

Impact of decipher test on adjuvant and salvage treatments received following radical prostatectomy.

Impact of decipher test on adjuvant and salvage treatments received following radical prostatectomy.

First Author: John L. Gore

First Author: Ketan K. Badani